News on in vitro diagnostics for allergy testing.

ALK will market Rellergen's Bio-IC lab-on-a-chip technology to more than 190 hospitals in China. The technology uses a blood sample to screen up to 20 different allergens.

The companies will provide allergy diagnosis and testing services to clinicians, hospitals, and private laboratories in Southeast Asia.

Cepheid noted that the cartridge is not currently part of its five-year commercial plan, but the firm is in discussions with outside parties to push development forward.

Called the Antimicrobial Resistance Diagnostic Challenge, the competition is a joint effort between the NIH and the HHS preparedness office.